Header Logo

Connection

David Hoaglin to Benzenesulfonates

This is a "connection" page, showing publications David Hoaglin has written about Benzenesulfonates.
Connection Strength

0.814
  1. Hoaglin DC. An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma - a flawed analysis and a problematic response. Expert Opin Pharmacother. 2013 Aug; 14(12):1705-6.
    View in: PubMed
    Score: 0.427
  2. Hoaglin DC, Cislo PR. An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma - a flawed analysis? Expert Opin Pharmacother. 2012 May; 13(7):1077-8; author reply 1079-80.
    View in: PubMed
    Score: 0.388
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.